ME Therapeutics Holdings, Inc. (TSE:METX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ME Therapeutics Holdings Inc., a Vancouver-based biotech firm specializing in innovative cancer immunotherapies, has announced CEO Dr. Salim Dhanji’s participation in the Bloom Burton & Co. Healthcare Investor Conference and an interview on CSE TV. The conference, which provides a platform for one-on-one investor meetings, will be held in Toronto on April 16-17, 2024. These events mark a strategic effort by ME Therapeutics to increase investor awareness as they continue to progress in the field of myeloid targeted immuno-oncology research.
For further insights into TSE:METX stock, check out TipRanks’ Stock Analysis page.